Atorvastatin donor pretreatment prevents ischemia/reperfusion injury in renal transplantation in rats: Possible role for aldose-reductase inhibition

被引:37
作者
Gottmann, Uwe
Brinkkoetter, Paul T.
Hoeger, Simone
Gutermann, Katrin
Coutinho, Zora Martins
Ruf, Tobias
Hui, Song
Liu, Zhenzi
Schnuelle, Peter
van der Woude, Fokko J.
Braun, Claude
机构
[1] Heidelberg Univ, Univ Hosp Mannheim, Dept Med Nephrol Endocrinol Rheumatol, D-68167 Mannheim, Germany
[2] Hop Kirchberg, Serv Med Interne & Nephrol, Luxembourg, Luxembourg
关键词
rat; kidney; transplantation; statin; ischemia/reperfusion;
D O I
10.1097/01.tp.0000281410.85659.48
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The aim of the present study was to evaluate the effect of donor pretreatment with atorvastatin on ischemia/reperfusion (I/R) injury in renal transplantation in rats. Methods. Donor rats were pretreated orally with atorvastatin or vehicle 2 days prior to explantation. Kidneys were stored for 24 hr at degrees C in University of Wisconsin solution and transplanted into isogeneic or allogeneic recipients. Results. Donor treatment with atorvastatin improved initial graft function, reduced renal inflammation, and the number of TUNEL-positive cells in renal tissue after prolonged cold storage and isogeneic transplantation. In the allogeneic transplantation model, donor treatment with atorvastatin reduced renal inflammation in grafts harvested after 5 days, but no improvement of long-term graft survival (24 weeks) could be observed. A genome wide gene expression profile of donor kidneys from atorvastatin treated or vehicle treated rats revealed a fivefold downregulation of aldose reductase in all atorvastatin treated animals (P < 0.01). Donor treatment with an aldose-reductase inhibitor improved kidney function and reduced renal inflammation after prolonged cold storage and isogeneic transplantation. Conclusion. Our data suggest that downregulation of aldose reductase in renal tissue might underlie the protective effect of donor atorvastatin treatment. Donor pretreatment with a statin or an aldose reductase inhibitor could offer a new treatment strategy to prevent transplantation associated tissue injury.
引用
收藏
页码:755 / 762
页数:8
相关论文
共 42 条
[41]   Protective effect of HMG-CoA reductase inhibitor on experimental renal ischemia-reperfusion injury [J].
Yokota, N ;
O'Donnell, M ;
Daniels, F ;
Burne-Taney, M ;
Keane, W ;
Kasiske, B ;
Rabb, H .
AMERICAN JOURNAL OF NEPHROLOGY, 2003, 23 (01) :13-17
[42]  
YOKOYAMA I, 1994, CLIN TRANSPLANT, V8, P101